jama glp-1 JAMA Internal Medicine patient information on GLP-1 medications. https://t.co/eaH2CIG333

JAMA - #GLP1 medicines now address weight loss and other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety. https://ja.ma/46Dy7Fw

20.68

★★★★☆4.8 (126)

💬 Perspective: #GLP-1 receptor agonist therapy provides substantial weight loss but increases risk of muscle mass reduction; exercise, especially resistance training, shows efficacy in preventing weight regain and maintaining muscle mass. https://t.co

22.94

★★★★★4.9 (98)

Ophthalmic Complications Observed After Use of GLP-1 Agonists

26.16

★★★★★5.0 (157)

JAMA article on GLP-1 drugs: a closer look | Barry Sears posted on the topic

29.52

★★★★★4.7 (84)

On Monday, JAMA published a summary of the new @WHO recommendations on the use of #GLP1 in the treatment of obesity in adults. , In a webinar, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD,

27.99

★★★★★4.9 (203)

New JAMA Data Brief 📊 About 1 in 5 US adults with type 2 diabetes were already using the popular class of medications called glucagon-like peptide 1 (GLP-1) receptor agonists by 2022,

21.26

★★★★★5.0 (176)

Glucagon-like peptide-1 receptor agonists (#GLP1 RAs) may improve hidradenitis suppurativa outcomes by inducing weight loss and reducing inflammation. https://t.co/Rt1GQrkiWj

24.81

★★★★★4.8 (132)